Faculty Profiles - ANDO Yuichi

Papers - ANDO Yuichi

Division display 101 - 120 of about 124 ／ All the affair displays >>

Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).

Ezaka, K; Nakayama, G; Yokoyama, H; Matsui, T; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) 2018.2

Randomized phase II trial of CapOX plus bevacizumab versus CapIRI plus bevacizumab as first-line treatment in Japanese patients with metastatic colorectal cancer (CCOG-1201).

Sasahara, M; Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Ishiyama, A; Matsui, T; Nakayama, H; Kobayashi, D; Umeda, S; Sunagawa, Y; Murotani, K; Ando, Y; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 36 ( 4 ) 2018.2

Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan. Reviewed

Sachi Morita, Toyone Kikumori, Nobuyuki Tsunoda, Takahiro Inaishi, Yayoi Adachi, Akiko Ota, Masahiro Shibata, Ayumu Matsuoka, Kenichi Nakanishi, Dai Takeuchi, Takehumi Mizutani, Tomoya Shimokata, Hiromichi Hayashi, Osamu Maeda and Yuichi Ando

Int J Clin Oncol Vol. 23 ( 1 ) page： 195 - 200 2018.2

Guidelines for treatment of renal injury during cancer chemotherapy 2016

Horie, S; Oya, M; Nangaku, M; Yasuda, Y; Komatsu, Y; Yanagita, M; Kitagawa, Y; Kuwano, H; Nishiyama, H; Ishioka, C; Takaishi, H; Shimodaira, H; Mogi, A; Ando, Y; Matsumoto, K; Kadowaki, D; Muto, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 22 ( 1 ) page： 210 - 244 2018.2

Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancer. Reviewed

Naomi Hayashi, Ayumu Matsuoka, Hidemi Goto, Momokazu Gotoh, Hitoshi Kiyoi, Yasuhiro Kodera, Masato Nagino, Fumio Nagashima, Yuichi Ando.

J Geriatr Oncol Vol. 9 ( 1 ) page： 84 - 86 2018.1

Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan

Maeda, O; Yokoyama, Y; Yamaguchi, J; Ota, A; Matsuoka, A; Morita, S; Inoue, M; Mizutani, T; Shimokata, T; Urakawa, H; Mitsuma, A; Nagino, M; Ando, Y

ANNALS OF ONCOLOGY Vol. 28 page： 69 - 69 2017.11

FDA Approval Summary: Sonidegib-Letter

Gyawali, B; Ando, Y

CLINICAL CANCER RESEARCH Vol. 23 ( 19 ) page： 5993 - 5993 2017.10

Gemcitabine plus cisplatin and S-1 for biliary tract cancer: a single institute analysis

Maeda, O; Shimokata, T; Mizutani, T; Inoue, M; Matsuoka, A; Ota, A; Mizuno, T; Ebata, T; Nagino, M; Ando, Y

ANNALS OF ONCOLOGY Vol. 28 page： 50 - 50 2017.10

Correlation and differences in Effect sizes between Progression Free Survival (PFS) and Overall Survival (OS) among PD-1 inhibitors

Gyawali, B; Shimokata, T; Ando, Y

ANNALS OF ONCOLOGY Vol. 28 2017.9

A phase 1 study of BYL719, an a-isoform selective PI3K inhibitor, in Japanese patients with advanced solid malignancies

Tomomatsu, J; Iwasa, S; Saka, H; Takahashi, S; Nakano, K; Morita, S; Inoue, M; Nakahama, H; Kogure, Y; Kakizume, T; Natsume, K; Aoki, T; Quadt, C; Yamada, Y; Ando, Y

ANNALS OF ONCOLOGY Vol. 28 2017.9

Erratum: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review.

Yamamoto E, Niimi K, Fujikake K, Nishida T, Murata M, Mitsuma A, Ando Y, Kikkawa F

Molecular and clinical oncology Vol. 7 ( 3 ) page： 510 2017.9

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

Nakayama, G; Ishigure, K; Yokoyama, H; Uehara, K; Kojima, H; Ishiyama, A; Hayashi, N; Takano, N; Hattori, N; Kobayashi, D; Tanaka, C; Hayashi, M; Kanda, M; Yamada, S; Sugimoto, H; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

BMC CANCER Vol. 17 ( 1 ) page： 243 2017.4